De novo generation and enhanced suppression of human CD4+ CD25+ regulatory T cells by retinoic acid

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 4119-4126

  Wang, Jun ^a   Huizinga, Tom W J ^a   Toes, Rene E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL EXPANSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 70349310093     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901065     Document Type: Article

References (49)

1. + regulatory T cells promote experimental transplantation tolerance. Blood 109: 827-835.
2. + regulatory T cells. J. Immunol. 170: 3939-3943.
3. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465. (Pubitemid 38780401)
4. + regulatory T cells. Arthritis Rheum. 52: 2212-2221.
5. + regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 180: 2747-2751.
6. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962. (Pubitemid 40979735)
7. high T cells gives rise to homogeneous regulatory T cell lines upon in vitro expansion. Blood 108: 4260-4267.
8. + T regulatory cells by activation independent expression of FOXP3. Mol. Ther. 16: 194-202.
9. high regulatory T cells. Blood 104: 895-903.
10. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
11. Ziegler, S. F. 2007. FOXP3: not just for regulatory T cells anymore. Eur. J. Immunol. 37: 21-23. (Pubitemid 46128782)
12. Roncarolo, M. G., and S. Gregori. 2008. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 38: 925-927.
13. + T reg cells. J. Exp. Med. 203: 1701-1711.
14. Peters, J. H., F. W. Preijers, R. Woestenenk, L. B. Hilbrands, H. J. Koenen, and I. Joosten. 2008. Clinical grade Treg: GMP isolation, improvement of purity by CD127 depletion, Treg expansion, and Treg cryopreservation. PLoS ONE 3: e3161.
15. +/+ T cells is discriminated by membrane- bound tumor necrosis factor α. Arthritis Rheum. 58: 1609-1618.
16. + regulatory T cells. J. Immunol. 180: 858-869.
17. pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
18. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200: 277-285.
19. high T regulatory cells. Blood 108: 253-261.
20. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
21. + T cells from patients with type 1 diabetes. Diabetes 54: 92-99.
22. + regulatory T cells. Int. Immunol. 16: 1643-1656.
23. + Tregs. J. Clin. Invest. 115: 3276-3284.
24. - T cells. J. Clin. Invest. 112: 1437-1443.
25. - cells. Proc. Natl. Acad. Sci. USA 102: 4103-4108.
26. Pillai, V., S. B. Ortega, C. K. Wang, and N. J. Karandikar. 2007. Transient regulatory T cells: a state attained by all activated human T cells. Clin. Immunol. 123: 18-29. (Pubitemid 46401504)
27. Rao, P. E., A. L. Petrone, and P. D. Ponath. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174: 1446-1455.
28. + T cells. Eur. J. Immunol. 37: 129-138.
29. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
30. +FOXP3 T cells by T cell receptor stimulation is transforming growth factor β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
31. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260. (Pubitemid 47076203)
32. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
33. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785.
34. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-trans-retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J. Exp. Med. 204: 1765-1774.
35. Schambach, F., M. Schupp, M. A. Lazar, and S. L. Reiner. 2007. Activation of retinoic acid receptor α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37: 2396-2399. (Pubitemid 47423609)
36. Elias, K. M., A. Laurence, T. S. Davidson, G. Stephens, Y. Kanno, E. M. Shevach, and J. J. O'Shea. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020.
37. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181: 2277-2284.
38. high cells. Immunity 29: 758-770.
39. + Treg cell conversion of naive T cells. Immunity 30: 471-472.
40. + regulatory T cells. J. Immunol. 179: 3724-3733.
41. -T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 181: 1683-1691.
42. Pillai, V., and N. J. Karandikar. 2008. Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 111: 463-464.
43. + regulatory T cells. Proc. Natl. Acad. Sci. USA 104: 18169-18174.
44. - T cells. J. Immunol. 179: 2041-2045.
45. Takaki, H., K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi. 2008. STAT6 Inhibits TGF-β1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283: 14955-14962.
46. Allan, S. E., G. X. Song-Zhao, T. Abraham, A. N. McMurchy, and M. K. Levings. 2008. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol. 38: 3282-3289.
47. Rudensky, A. Y., M. Gavin, and Y. Zheng. 2006. FOXP3 and NFAT: partners in tolerance. Cell 126: 253-256.
48. + regulatory T cell function. Science 322: 271-275.
49. Kolar, P., K. Knieke, J. K. Hegel, D. Quandt, G. R. Burmester, H. Hoff, and M. C. Brunner-Weinzierl. 2009. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 60: 123-132.